Triple-negative breast cancer treatments being investigated include checkpoint inhibitors, agents that target the androgen receptor pathways, and antibody-drug conjugates.
Original Article: Treatment for Triple-Negative Breast Cancer Slowly Moving Forward
NEXT ARTICLE